Nucleus Software Exports Limited (IN:NUCLEUS)
:NUCLEUS
Top Page
Nucleus Software Exports Limited
(NUCLEUS)
Select Model
Select Model
Rating:64Neutral
Price Target:
₹889.00
▼(-3.29% Downside)
Action:DowngradedDate:03/19/26
The score is driven primarily by strong fundamentals (revenue growth, profitability, and a low-leverage balance sheet), tempered by weakening cash flow in 2025. Technical indicators are the main drag, with the stock trading below key moving averages and negative MACD signaling bearish momentum. Valuation is mid-range with a moderate P/E and a modest dividend yield.
Positive Factors
Consistent revenue and margins
Sustained revenue growth and healthy gross and net margins indicate durable product-market fit in banking software. This supports predictable operating leverage, funds reinvestment in product and services, and underpins long-term profitability even with occasional margin dips.
Negative Factors
Decline in operating and free cash flow
A drop in operating and free cash flow reduces internal funding capacity for product development, hiring, or strategic investments. If the decline persists it could force trade-offs between growth initiatives and shareholder returns, weakening long-term scalability.
Read all positive and negative factors
Positive Factors
Negative Factors
Consistent revenue and margins
Sustained revenue growth and healthy gross and net margins indicate durable product-market fit in banking software. This supports predictable operating leverage, funds reinvestment in product and services, and underpins long-term profitability even with occasional margin dips.
Read all positive factors
Nucleus Software Exports Limited (NUCLEUS) vs. iShares MSCI India ETF (INDA)
Market Cap
₹19.76B
Dividend Yield1.34%
Average Volume (3M)1.28K
Price to Earnings (P/E)29.1
Beta (1Y)1.58
Revenue Growth6.64%
EPS Growth4.63%
CountryIN
Employees1,890
SectorTechnology
Sector Strength88
IndustrySoftware - Application
Share Statistics
EPS (TTM)7.90
Shares Outstanding26,325,306
10 Day Avg. Volume1,083
30 Day Avg. Volume1,280
Financial Highlights & Ratios
PEG Ratio-0.93
Price to Book (P/B)2.64
Price to Sales (P/S)2.59
P/FCF Ratio15.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)62.9
Revenue Forecast (FY)₹8.82B
Nucleus Software Exports Limited Business Overview & Revenue Model
Company Description
Nucleus Software Exports Limited provides mission critical lending and transaction banking products to the financial services industry in India, the Far East, South East Asia, Europe, the Middle East, Africa, Australia, and internationally. Its pr...
How the Company Makes Money
NUCLEUS primarily earns revenue by selling and supporting its banking software products to financial institutions. Key revenue streams typically include: (1) software license fees for its core products (often sold as perpetual licenses and/or as s...
Nucleus Software Exports Limited Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
80
Positive
Cash Flow
78
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.55B | 8.32B | 8.26B | 6.34B | 4.97B | 5.14B |
| Gross Profit | 3.13B | 2.98B | 3.31B | 1.88B | 765.00M | 4.96B |
| EBITDA | 2.26B | 1.68B | 2.71B | 1.91B | 713.70M | 1.69B |
| Net Income | 1.68B | 1.63B | 1.92B | 1.28B | 409.10M | 1.18B |
Balance Sheet | ||||||
| Total Assets | 0.00 | 11.53B | 11.14B | 8.74B | 7.37B | 8.85B |
| Cash, Cash Equivalents and Short-Term Investments | 3.59B | 3.60B | 4.01B | 2.77B | 3.41B | 5.02B |
| Total Debt | 0.00 | 20.00M | 45.90M | 62.60M | 23.30M | 63.00M |
| Total Liabilities | -8.14B | 3.39B | 3.37B | 2.64B | 2.43B | 2.13B |
| Stockholders Equity | 8.14B | 8.14B | 7.77B | 6.11B | 4.94B | 6.72B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.36B | 1.93B | 461.40M | 334.30M | 1.12B |
| Operating Cash Flow | 0.00 | 1.51B | 2.22B | 498.40M | 576.70M | 1.15B |
| Investing Cash Flow | 0.00 | -207.80M | -1.97B | -127.00M | 1.59B | -1.26B |
| Financing Cash Flow | 0.00 | -1.26B | -301.60M | -226.50M | -2.13B | -133.40M |
Nucleus Software Exports Limited Technical Analysis
Negative
919.20
Price Trends
837.93
Negative
888.03
Negative
976.39
Negative
Market Momentum
-16.39
Negative
39.45
Neutral
28.41
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:NUCLEUS, the sentiment is Negative. The current price of 919.2 is above the 20-day moving average (MA) of 775.30, above the 50-day MA of 837.93, and below the 200-day MA of 976.39, indicating a bearish trend. The MACD of -16.39 indicates Negative momentum. The RSI at 39.45 is Neutral, neither overbought nor oversold. The STOCH value of 28.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:NUCLEUS.
Nucleus Software Exports Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ₹15.40B | 21.87 | ― | 0.42% | 21.17% | 27.66% | |
64 Neutral | ₹19.76B | 29.12 | ― | 1.34% | 6.64% | 4.63% | |
62 Neutral | ₹87.89B | 118.88 | ― | 0.69% | 15.87% | 39.55% | |
62 Neutral | ₹29.44B | 25.72 | ― | 3.06% | 8.36% | 36.68% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
53 Neutral | ₹13.74B | 163.07 | ― | ― | 20.41% | ― |
* Technology Sector Average
IN:NUCLEUS
Nucleus Software Exports Limited
750.55
-42.82
-5.40%
IN:INTELLECT
Intellect Design Arena Ltd
629.75
-58.85
-8.55%
IN:RAMCOSYS
Ramco Systems Limited
366.90
35.25
10.63%
IN:ROSSTECH
Rossell Techsys Limited
682.60
399.43
141.06%
IN:RSYSTEMS
R Systems International Limited
248.50
-66.85
-21.20%
IN:SAKSOFT
Saksoft Limited
116.20
-30.14
-20.60%
Nucleus Software Exports Limited Corporate Events
Nucleus Software Names Yasmin Javeri Krishan as Chairperson to Strengthen Governance and Inclusive Leadership
Mar 16, 2026
Nucleus Software has appointed Mrs. Yasmin Javeri Krishan as Chairperson of its Board of Directors, effective March 19, 2026, elevating her from her current role as a Non-Executive, Independent Director and long-time board member of its Singapore ...
Nucleus Software Reshapes Board Leadership and Governance Structure
Mar 16, 2026
Nucleus Software Exports Limited’s board has approved the retirement of independent director and board chairperson Siddhartha Mahavir Acharya at the close of business on March 18, 2026, upon completion of his second consecutive five‑ye...
Nucleus Software Reshapes Board Leadership and Committees, Adds Culture Panel
Mar 16, 2026
Nucleus Software Exports Limited has announced changes to its board leadership, with independent director and current chairperson Siddhartha Mahavir Acharya set to retire on March 18, 2026, upon completion of his second consecutive five-year term....
Nucleus Software revamps board leadership and committees as chairperson retires
Mar 16, 2026
Nucleus Software Exports Limited has announced that Independent Director and Chairperson of the Board, Mr. Siddhartha Mahavir Acharya, will retire at the close of business on March 18, 2026, upon completion of his second consecutive five-year term...
Nucleus Software Names Former IAS Officer Nitin R. Gokarn as Independent Director
Feb 10, 2026
Nucleus Software Exports Limited has appointed Dr. Nitin R. Gokarn as an additional non-executive independent director on its board, effective February 10, 2026, for a term of up to five years, subject to shareholder approval by special resolution...
Nucleus Software Marks 25 Years in Japan, Reaffirms Long-Term Fintech Commitment
Jan 8, 2026
Nucleus Software Japan K.K., the Japan arm of Nucleus Software Exports Limited, marked its 25th anniversary in the Japanese market with a celebratory event at the Imperial Hotel in Tokyo, attended by senior executives from major financial institut...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.